Orchid Cellmark to Announce Third Quarter 2007 Financial Results on November 1, 2007

PRINCETON, N.J., Oct. 15 Orchid Cellmark Inc.(Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services,will release its third quarter 2007 financial results on Thursday, November 1,2007 at approximately 7:00 am EDT, and is hosting a conference call andwebcast to discuss the results at 10:00 a.m. EDT on the same day. Managementwill discuss financial results for the third quarter 2007 as well as operatinghighlights. A question-and-answer session will follow management'sdiscussion. All interested parties are encouraged to listen to the liveconference call or the live or archived webcast.

About Orchid Cellmark

Orchid Cellmark is a leading provider of identity DNA testing services forthe human identity and agriculture markets. In the human identity area, thecompany provides DNA testing services for forensic, family relationship andsecurity applications. In the agriculture field, Orchid Cellmark provides DNAtesting services for selective trait breeding. Orchid Cellmark's strongmarket positions in these segments reflect the company's accreditedlaboratories in the U.S. and U.K., its innovative genetic analysistechnologies and expertise, and the world-renowned Cellmark brand that hasbeen associated with exceptional quality, reliability and customer service fornearly two decades. More information on Orchid Cellmark can be found atwww.orchid.com.Conference Call Details Date and Time: Thursday, November 1, 2007 at 10:00am EDT Dial-In: US/Canada: (877) 266-0703 Int'l/Local: (706) 643-7682 Conference ID: 20685333 Webcast: Live webcast and replay available via the Investor Relations section of the company's website at www.orchid.com. The webcast will be available for 90 days.

SOURCE Orchid Cellmark Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...